The Guts to Make a Change
March 6, 2015 3:14 pmOur CEO Francesca Manglaviti features in ProBono Australia as the Change Maker of the week! Check out the full story…>Read More
Our CEO Francesca Manglaviti features in ProBono Australia as the Change Maker of the week! Check out the full story…>Read More
US researchers have identified specific gene expressions and microbes associated with the inflammatory bowel disease Crohn’s disease. The researchers compared…>Read More
CCA is delighted to welcomed Reece Plumbing as a new national Can’t Wait Affiliate. The Can’t Wait Card is issued…>Read More
Corporate and philanthropic donations now needed to ensure program is fully implemented. In December, the Federal Government announced an historic…>Read More
A ground breaking Australian study, supported by Gandel Philanthropy through Crohn’s & Colitis Australia (CCA), took out top honours at…>Read More
On 1 April 2014, Remicade® (infliximab) was made available on the Pharmaceutical Benefits Scheme (PBS) in limited circumstances for patients…>Read More
A new online tool that aims to radically improve cancer prevention in patients with inflammatory bowel disease (IBD) was launched…>Read More
13 December, 2013 CCA is delighted to welcome an historic $500,000 matched funding agreement granted by the Federal Government that…>Read More
Congratulations and THANK YOU to everyone who took part in the Changing Lives Challenge in 2013. Our participants raised more…>Read More
Crohn’s & Colitis Australia has been awarded a Victorian Government Health Condition support grant, enabling us to extend our support…>Read More